Patricia L. Allen
VP of Finance and Treasurer, Alnylam Pharmaceuticals.
Companies
- Zenas BioPharma, Inc.Board member Sep 12, 2024 to now1
- Deciphera Pharmaceuticals, Inc.Board member Sep 28, 2017 to Jun 11, 20242
- Proteostasis Therapeutics (United States)Board member Dec 28, 2020 to Jun 4, 20213
- Zafgen (United States)Chief financial officer Mar 3, 2015 to Jan 24, 20194
- Zafgen (United States)Officer Jun 18, 2014 to Jun 18, 20145
- Alnylam PharmaceuticalsVP of Finance and Treasurer Jan 9, 2006 to Dec 10, 20106
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Zenas BioPharma, Inc. ZBIO19,860 shares7$530.7K at $26.72Feb 13, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 13, 2026Bought 4,160 shares at $26.36 of Zenas BioPharma, Inc.7
- Feb 12, 2026Bought 5,000 shares at $26.50 of Zenas BioPharma, Inc.7
- Feb 12, 2026Bought 5,700 shares at $24.34 of Zenas BioPharma, Inc.7
- Feb 12, 2026Bought 5,000 shares at $23.77 of Zenas BioPharma, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARZenas BioPharma, Inc., Board member
- 2
- 3
- 4
- 5SEC EDGARZafgen (United States), Officer
- 6
- 7